Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564636 · ClinicalTrials.gov registry record
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Smith & Nephew.
- Active
- Registry status
- 119
- Enrollment target
- 10
- Study locations
NCT06564636 is a study of Osteoarthritis and Avascular Necrosis that is active but no longer recruiting, run by Smith & Nephew. The registered enrollment target is 119 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower). The trial reports 10 study locations across 10 states.
The verdict
NCT06564636, a study of Osteoarthritis and Avascular Necrosis, is active but no longer recruiting, sponsored by Smith & Nephew.
- ACTIVE NOT RECRUITING
- Registry status
- 119 participants
- Enrollment target
- 10
- Study locations
Study Summary
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
Conditions Studied
Interventions
- DEVICE CATALYSTEM
Study Locations (10)
California
- University of California at San Francisco - San Francisco
Connecticut
- Connecticut Orthopaedic Institute - Hamden
Florida
- Orlando Health Inc. - Orlando
Illinois
- Illinois Bone and Joint Institute - Des Plaines
New York
- NYU Langone Health Orthopedic Hospital - New York
North Carolina
- Duke Health - Morrisville
Alberta
- University of Alberta - Edmonton
British Columbia
- University of British Columbia - Vancouver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2024-09-26 |
| Est. Completion | 2036-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06564636
The ClinicalTrials.gov registry entry for NCT06564636 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (85% lower). The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which CATALYSTEM is the first listed.
NCT06564636 reports 10 study locations spanning 10 distinct geographic areas - top geographies include California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT06564636 about?
NCT06564636 is a clinical study titled "A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System". A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
What is the current status of trial NCT06564636?
This trial is currently active not recruiting. The enrollment target is 119 participants. The study started on 2024-09-26. Estimated completion is 2036-03.
What conditions does trial NCT06564636 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Inflammatory Arthritis, Degenerative Joint Disease.
What interventions are being tested in trial NCT06564636?
The interventions under investigation include: CATALYSTEM (DEVICE).
Who is sponsoring clinical trial NCT06564636?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564636 being conducted?
This trial has 10 study locations across California, Connecticut, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.